HCPCS Code Descriptor:
Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
00026-3942-25, 00026-3944-25, 00026-3946-25, 00026-3948-25
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
JIVI is a Hematology drug manufactured by Bayer and administered via the Intravenous route of administration. The J Code: J7208 is aligned to the drug JIVI.
JIVI is used to control the bleeding in patients with a certain blood disorder. This medication is an artificial form of factor VIII, which helps thicken and clot the blood. JIVI is manufactured by Bayer pharmaceuticals. This drug has been aligned to the HCPS code J7208 and has been since July 1st, 2019, and is still currently aligned to this code. Before J7208, JIVI was aligned to the HCPCS code C9141 from April 1st, 2019, to June 30th, 2019. Patient assistance programs for this medication can be found through the Bayer US Assistance Foundation.